5IZ6
Protein-protein interaction
5IZ6 の概要
| エントリーDOI | 10.2210/pdb5iz6/pdb |
| 関連するPDBエントリー | 5IZ8 5IZ9 5IZA |
| 分子名称 | Adenomatous polyposis coli protein, PHQ-ALA-GLY-GLU-ALA-LEU-TYR-GLU-NH2, SULFATE ION, ... (5 entities in total) |
| 機能のキーワード | apc, asef, colon cancer, drug discovery, protein binding-inhibitor complex, protein binding/inhibitor |
| 由来する生物種 | Homo sapiens (Human) 詳細 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 40372.80 |
| 構造登録者 | |
| 主引用文献 | Jiang, H.,Deng, R.,Yang, X.,Shang, J.,Lu, S.,Zhao, Y.,Song, K.,Liu, X.,Zhang, Q.,Chen, Y.,Chinn, Y.E.,Wu, G.,Li, J.,Chen, G.,Yu, J.,Zhang, J. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. Nat. Chem. Biol., 13:994-1001, 2017 Cited by PubMed Abstract: The binding of adenomatous polyposis coli (APC) to its receptor Asef relieves the negative intramolecular regulation of Asef and leads to aberrant cell migration in human colorectal cancer. Because of its crucial role in metastatic dissemination, the interaction between APC and Asef is an attractive target for anti-colorectal-cancer therapy. We rationally designed a series of peptidomimetics that act as potent inhibitors of the APC interface. Crystal structures and biochemical and cellular assays showed that the peptidomimetics in the APC pocket inhibited the migration of colorectal cells by disrupting APC-Asef interaction. By using the peptidomimetic inhibitor as a chemical probe, we found that CDC42 was the downstream GTPase involved in APC-stimulated Asef activation in colorectal cancer cells. Our work demonstrates the feasibility of exploiting APC-Asef interaction to regulate the migration of colorectal cancer cells, and provides what to our knowledge is the first class of protein-protein interaction inhibitors available for the development of cancer therapeutics targeting APC-Asef signaling. PubMed: 28759015DOI: 10.1038/nchembio.2442 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.15 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






